title: Metastatic prostate cancer in transsexual diagnosed after three decades of estrogen therapy.
abstract: The incidence of prostate cancer in transsexual patients is very low with only few reported cases. Many years before presenting with prostate cancer, these patients receive hormone ablation as a part of their gender therapy. Their disease is already defined as castrate resistant, and the treatment and follow-up of such patients remains a challenge. We report a case of a male-to-female transgender woman who was diagnosed with metastatic prostate cancer, 31 years post-feminization.
authors.affiliation: St. James University Hospital, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
authors.forename: Rafal
authors.initials: R
authors.lastname: Turo
authors.forename: Samer
authors.initials: S
authors.lastname: Jallad
authors.forename: Stephen
authors.initials: S
authors.lastname: Prescott
authors.forename: William Richard
authors.initials: WR
authors.lastname: Cross
references.citation: J Clin Oncol. 2001 Mar 1;19(5):1304-11
references.pmid: 11230472
references.citation: Cancer. 1998 Feb 1;82(3):531-7
references.pmid: 9452271
references.citation: BJU Int. 2005 Dec;96(9):1219-23
references.pmid: 16287434
references.citation: Br J Urol. 1998 May;81(5):776
references.pmid: 9634067
references.citation: Clin Genitourin Cancer. 2007 Jun;5(5):344-6
references.pmid: 17645834
references.citation: JAMA. 2005 Jul 13;294(2):238-44
references.pmid: 16014598
references.citation: N Engl J Med. 2004 Oct 7;351(15):1502-12
references.pmid: 15470213
references.citation: J Clin Oncol. 2005 Nov 10;23(32):8253-61
references.pmid: 16278481
references.citation: Br J Urol. 1994 Feb;73(2):217
references.pmid: 8131033
references.citation: J Clin Endocrinol Metab. 1999 Dec;84(12):4324-31
references.pmid: 10599682
references.citation: Cancer Res. 2001 Mar 1;61(5):1919-26
references.pmid: 11280747